HEALTH● LOWAug 6 · Aug 6, 2026, 2:30 PM
HOMETOWN HEALTH : GLP - 1 drug , Tirzepatide , linked to lower heart attack risk in high - risk patients
wdbj7.com · United States
A GLP-1 drug, Tirzepatide, has been linked to a reduced risk of heart attacks in high-risk patients. This medical finding could offer a new therapeutic approach for cardiovascular health.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH52m agoBhutan First in WHO South-East Asia to End Dog-Transmitted Human RabiesHuman ProgressHEALTH53m agoThailand Eliminates Rubella as a Public Health ProblemHuman ProgressHEALTH1h agoHere's what to eat to protect the good bacteria in your mouthBBC AfriqueHEALTH2h agoDiphtheria: Bauchi says outbreak under control as schools reopenVanguard Nigeria